PET CT Scan Before Chemotherapy — Why It Cannot Be Skipped & What It Shows

If your oncologist has referred you for a PET CT scan before your chemotherapy begins — this page explains the three reasons why this scan is clinically essential, what it will show, what happens if it finds something unexpected, and how to get it done in time when your chemotherapy schedule cannot wait.

FDG PET CT before chemotherapy costs ₹9,000–₹14,000 at AERB-licensed nuclear medicine centres across Delhi NCR — with same-week availability that matches your chemotherapy timeline without the 4–8 week wait at government centres.

The Three Reasons Your Oncologist Ordered This Scan

Patients often assume the pre-chemotherapy PET CT is a routine formality — one more scan before treatment begins. It is not. It serves three specific clinical purposes simultaneously, and all three matter.

Reason 1 — To Establish the Baseline

Every future PET CT scan in your treatment journey will be compared against this one.

FDG PET performed at baseline and during and after completion of chemotherapy provides prognostic information — a reduction in SUV of more than 80% from baseline was the best predictor for good response to further treatment, whereas progressive disease on PET correlated with an unfavourable outcome.

When your oncologist orders an interim PET CT after 2 cycles of chemotherapy — the nuclear medicine physician compares every FDG-avid site to what it looked like on your baseline scan. Without the baseline scan, that comparison is impossible. Without the comparison, the interim result cannot be reliably interpreted as a response or a failure.

The baseline scan is not just about today. It is the reference that makes every future scan meaningful.

Reason 2 — To Confirm or Change Your Staging

CT staging before PET CT frequently misses metabolically active disease that is too small to show a size change on CT — lymph nodes below the size threshold, early bone marrow involvement, small adrenal deposits.

PET CT modified the staging for 26% of Stage I breast cancer patients, 29% of Stage IIA, 46% of Stage IIB, 58% of Stage IIIA, and 100% of Stage IIIB patients. PET CT detected distant metastasis in 29% of patients whose pre-PET CT staging had not identified metastatic disease.

FDG PET CT altered the TNM stage in 31% of head and neck cancer patients before chemoradiotherapy — upstaging disease in 20% and downstaging in 11%.

In plain language: approximately 1 in 3 patients will have their cancer stage changed by PET CT — either upward (more disease found) or downward (less disease than CT suggested). Both changes affect treatment.

Reason 3 — To Select the Right Chemotherapy

In some cancers — particularly lymphoma, lung cancer, and head and neck cancers — the PET CT staging result directly determines which chemotherapy regimen is used. A Stage II lymphoma patient and a Stage IV lymphoma patient receive different treatment intensity. The PET CT is what determines which stage you are — and therefore what treatment you receive.

All three reasons apply simultaneously. The pre-chemotherapy PET CT is a single scan that performs three clinical functions. Delaying or skipping it creates downstream clinical problems that compound over the entire treatment course.

What Happens If PET CT Finds Something Unexpected Before Chemotherapy

This is the specific anxiety driving most searches for this page. "What if the PET CT shows something worse than what my doctor already found?"

This is a legitimate concern — and the honest answer deserves respect.

If PET CT shows upstaging (more disease than expected):

In most cases, this means the chemotherapy regimen becomes more intensive — more cycles, a different drug combination, or the addition of radiotherapy to sites that would not otherwise have been treated. This is not worse news — it is more accurate news. Treating a Stage IV patient with a Stage II protocol would have been a significant clinical failure. The PET CT prevented that.

If PET CT shows downstaging (less disease than expected):

The chemotherapy may be de-escalated — fewer cycles, a less intensive regimen, or the possibility of surgery where previously only systemic treatment was planned. This is unambiguously positive news.

If PET CT shows disease at a completely unexpected site:

This occasionally happens — a small lung nodule showing FDG uptake in a patient being treated for abdominal cancer, an unsuspected brain metastasis. Your oncologist will discuss the clinical significance of each finding before proceeding with treatment.

The important perspective: A PET CT that finds unexpected disease before chemotherapy is not causing the problem — it is revealing it. That disease was present before the scan. The scan is giving your oncologist the complete picture they need to treat you correctly.

Cancer-by-Cancer Guide — Why Pre-Chemotherapy PET CT Matters for Your Specific Cancer

Lymphoma (Hodgkin and Non-Hodgkin)

The pre-chemotherapy PET CT is the most critical baseline scan in the entire lymphoma journey. International guidelines recommend that PET CT be used for routine staging of FDG-avid lymphomas using Deauville criteria.

The baseline PET CT maps every FDG-avid disease site — lymph nodes above and below the diaphragm, extranodal sites, spleen, bone marrow (in Hodgkin's). Every interim PET CT and end-of-treatment PET CT is scored relative to this baseline using the Deauville scale. Without a baseline scan, Deauville scoring is not possible.

What it changes: In Hodgkin's lymphoma — PET CT frequently reveals disease in sites missed by CT alone, including skeletal disease that changes the stage from early to advanced and therefore changes treatment intensity.

Lung Cancer (NSCLC)

FDG PET CT is widely adopted as the pre-radical staging test for lung cancer, providing more accuracy than either CT or PET alone. Pharmacy

For Stage III lung cancer patients receiving concurrent chemoradiotherapy — the pre-treatment PET CT is also used for radiation therapy target volume delineation. The metabolically active tumour boundary on PET CT is more precise than the anatomical boundary on CT alone, allowing the radiation oncologist to design a more accurate treatment field.

What it changes: In approximately 31% of Stage III NSCLC patients, PET CT changes the treatment plan — identifying additional disease sites or ruling out sites that appeared suspicious on CT alone.

Breast Cancer

PET CT detected distant metastasis in 29% of breast cancer patients whose pre-PET CT staging had not identified metastatic disease, and modified staging in 26–100% of patients depending on initial clinical stage.

For high-risk or locally advanced breast cancer (Stage IIB and above) — pre-chemotherapy PET CT identifies distant metastases that would fundamentally change treatment from curative to palliative intent. For patients being considered for neoadjuvant chemotherapy before surgery — the baseline PET CT allows assessment of how well the tumour responds metabolically to each cycle.

What it changes: In 29% of patients, PET CT identifies metastatic disease not seen on conventional staging — converting a curative treatment plan to a different approach.

Head and Neck Cancers

FDG PET CT altered the TNM stage in 31% of head and neck cancer patients before chemoradiotherapy — upstaging disease in 20% and downstaging in 11%.

For head and neck cancers being treated with concurrent chemoradiotherapy — PET CT is used for both staging confirmation and radiation therapy planning. The metabolic mapping of nodal disease by PET CT defines the radiation target more precisely than CT or MRI alone.

What it changes: In 31% of patients, the stage changes — with direct implications for the chemotherapy regimen and radiation field designed.

Cervical Cancer and Gynaecological Cancers

Pre-chemotherapy PET CT for cervical and endometrial cancers maps pelvic and para-aortic lymph node involvement with superior sensitivity to CT. Among patients with cervical cancer who had pre-treatment and post-treatment FDG PET, patients without residual abnormalities on FDG PET had an estimated 80% 5-year survival, compared with 32% in patients with residual abnormalities.

The pre-chemotherapy baseline directly determines the radiotherapy planning field — para-aortic node involvement visible on PET CT but not CT requires extended field radiation.

The Timing Problem — Why This Scan Cannot Wait

This is the operationally most important section for patients coordinating their pre-chemotherapy workup.

The clinical timeline: Most oncologists schedule the first chemotherapy cycle within 2–4 weeks of diagnosis confirmation. The pre-chemotherapy PET CT must happen before the first cycle — because chemotherapy itself changes FDG distribution in tumour tissue, making the post-treatment scan incomparable to a true untreated baseline.

The government hospital timing reality: AIIMS and Safdarjung government nuclear medicine departments offer PET CT at ₹3,500–₹6,000 — but typical wait times are 4–8 weeks. For a patient whose first chemotherapy cycle is scheduled in 2 weeks, a government hospital PET CT appointment is clinically unavailable.

The consequence of skipping the baseline: If the first chemotherapy cycle proceeds without a baseline PET CT:

• The oncologist treats without knowing the full metabolic disease extent
• Future interim and end-of-treatment PET CT scans have no baseline for comparison
• Deauville scoring in lymphoma cannot be performed without a baseline
• Response assessment becomes qualitative rather than quantitative

The EVE solution: AERB-licensed standalone nuclear medicine centres in Delhi NCR offer same-day to same-week FDG PET CT appointments. A patient whose chemotherapy starts in 10 days can have their baseline PET CT done within 3–5 days of calling EVE Healthcare. The scan quality is equivalent to any hospital radiology department.

Pre-Chemotherapy PET CT Cost in Delhi 2026

The honest recommendation: For most patients with a chemotherapy start date within 2–4 weeks — an AERB-licensed standalone nuclear medicine centre at ₹9,000–₹14,000 with same-week availability is the correct choice. The scan quality is equivalent. The timing aligns with the chemotherapy schedule. The cost saving over a hospital department is significant.

Preparation for Pre-Chemotherapy PET CT

Standard FDG whole body preparation applies:

24 hours before: Low-carbohydrate diet — no roti, rice, dal, fruit, or sugar. High-protein meals: chicken, fish, eggs, paneer, green vegetables.

6 hours before: Complete fast — water only. No chai, coffee, coconut water, or juice.

Day of scan: Water freely. Take all regular medications. Bring warm clothing.

Chemotherapy-specific note: If you are already on any pre-treatment medications — steroids, hormonal therapy, targeted agents — inform the nuclear medicine physician at booking. Some medications may affect FDG distribution and the physician should document this for baseline interpretation.

Diabetic patients: Contact EVE Healthcare at booking — we connect you with the nuclear medicine centre's team for a specific preparation protocol before your appointment.

Full preparation guide including Indian food-specific guidance → How to Prepare for PET CT →

What to Bring to Your Pre-Chemotherapy PET CT

This scan is your baseline — everything from it will be used for comparison throughout your treatment. Bring:

• Oncologist's referral specifying "baseline FDG PET CT pre-chemotherapy" or equivalent
• All previous imaging — CT scan, MRI, PET CT if any (even from another centre)
• Biopsy or pathology reports
• List of all current medications including any steroids or targeted agents
• CGHS Smart Card and referral letter if applicable
• Aadhaar card

The most important instruction: Ask the nuclear medicine centre for a CD of your DICOM images when you collect your report. Keep this CD. Every future PET CT centre will need it for comparison. Do not rely on digital delivery alone for a scan that will be referenced for months or years.

Area Guide — Pre-Chemotherapy PET CT in Delhi NCR

Clinical Note

From the reviewing nuclear medicine physician: The pre-chemotherapy PET CT is the scan that anchors the entire treatment assessment framework. Every subsequent scan — interim, end-of-treatment, surveillance — is read against this baseline. When a patient arrives having already had their first cycle of chemotherapy without a baseline PET CT, I can still perform the scan and describe current findings — but I cannot tell the oncologist how much the disease has changed, because I have nothing to compare it against. The interim PET CT without a baseline is descriptive rather than evaluative. The treatment decision that should be informed by objective metabolic response assessment becomes a judgement call. In a disease like lymphoma, where the interim PET CT result may determine whether the patient escalates to a more toxic regimen or de-escalates to a less toxic one — that distinction matters enormously. The baseline scan is not bureaucracy. It is the measurement that makes every subsequent measurement meaningful. Get it done before the first cycle. The cost and availability arguments for a standalone nuclear medicine centre are real — ₹9,000–₹14,000 and same-week availability versus ₹3,500 and 6 weeks at a government centre. When your first chemotherapy cycle is in 10 days, the 6-week option does not exist.

Book Your Pre-Chemotherapy PET CT in Delhi

Tell our team your chemotherapy start date and we will confirm the earliest available baseline PET CT slot that fits your timeline.

WhatsApp +91 9990032078 — say "FDG PET CT before chemotherapy" and your scheduled chemotherapy date. We confirm same-week availability across Delhi, Noida, and Gurgaon.

Also see: Whole Body PET CT Scan Cost Delhi → · FDG vs PSMA vs DOTANOC → · How to Prepare for PET CT → · PET CT Scan Lung Cancer Delhi → · PET CT Scan Lymphoma Delhi → · CGHS PET CT Rate Delhi